Advertisement
BYSI vs VNDA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BYSI is a StrongBuy and VNDA is a Hold.
BYSI's RSI Oscillator recovers from oversold territory
The RSI Oscillator for BYSI moved out of oversold territory on October 26, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 41 similar instances when the indicator left oversold territory. In 36 of the 41 cases the stock moved higher. This puts the odds of a move higher at 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 63 cases where BYSI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Momentum Indicator moved above the 0 level on October 30, 2026. You may want to consider a long position or call options on BYSI as a result. In 71 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for BYSI just turned positive on October 30, 2026. Looking at past instances where BYSI's MACD turned positive, the stock continued to rise in 36 of 50 cases over the following month. The odds of a continued upward trend are 72%.
Following a +14.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where BYSI advanced for three days, in 175 of 219 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
Bearish Trend Analysis
BYSI moved below its 50-day moving average on September 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BYSI crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BYSI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
BYSI broke above its upper Bollinger Band on September 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BYSI entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.744) is normal, around the industry mean (3.162). P/E Ratio (-3.787) is within average values for comparable stocks, (-1.064). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (131.622) among similar stocks. P/S Ratio (31.056) is also within normal values, averaging (439.647).
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. BYSI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BYSI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
VNDA's RSI Oscillator slumps oversold zone
The RSI Indicator for VNDA moved into overbought territory on October 30, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +1.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where VNDA advanced for three days, in 155 of 243 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
VNDA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VNDA as a result. In 71 of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for VNDA turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 38 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VNDA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Aroon Indicator for VNDA entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.041) is normal, around the industry mean (3.162). P/E Ratio (-0.817) is within average values for comparable stocks, (-1.064). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (131.622) among similar stocks. P/S Ratio (1.378) is also within normal values, averaging (439.647).
The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. VNDA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VNDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
BYSI | VNDA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 20 Undervalued | 53 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 98 | |
PRICE GROWTH RATING 1..100 | 87 | 81 | |
P/E GROWTH RATING 1..100 | 9 | 17 | |
SEASONALITY SCORE 1..100 | 90 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BYSI's Valuation (20) in the Pharmaceuticals Major industry is somewhat better than the same rating for VNDA (53) in the Biotechnology industry. This means that BYSI’s stock grew somewhat faster than VNDA’s over the last 12 months.
BYSI's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as VNDA (100) in the Biotechnology industry. This means that BYSI’s stock grew similarly to VNDA’s over the last 12 months.
VNDA's SMR Rating (98) in the Biotechnology industry is in the same range as BYSI (99) in the Pharmaceuticals Major industry. This means that VNDA’s stock grew similarly to BYSI’s over the last 12 months.
VNDA's Price Growth Rating (81) in the Biotechnology industry is in the same range as BYSI (87) in the Pharmaceuticals Major industry. This means that VNDA’s stock grew similarly to BYSI’s over the last 12 months.
BYSI's P/E Growth Rating (9) in the Pharmaceuticals Major industry is in the same range as VNDA (17) in the Biotechnology industry. This means that BYSI’s stock grew similarly to VNDA’s over the last 12 months.
| BYSI | VNDA | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 88% | 3 days ago 88% |
| Stochastic ODDS (%) | 3 days ago 84% | 3 days ago 80% |
| Momentum ODDS (%) | 3 days ago 80% | 3 days ago 75% |
| MACD ODDS (%) | 3 days ago 72% | 3 days ago 79% |
| TrendWeek ODDS (%) | 3 days ago 82% | 3 days ago 77% |
| TrendMonth ODDS (%) | 3 days ago 90% | 3 days ago 76% |
| Advances ODDS (%) | 5 days ago 80% | 4 days ago 64% |
| Declines ODDS (%) | 10 days ago 88% | 7 days ago 74% |
| BollingerBands ODDS (%) | 5 days ago 89% | 3 days ago 82% |
| Aroon ODDS (%) | 3 days ago 90% | 3 days ago 79% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BYSI’s FA Score shows that 2 FA rating(s) are green while VNDA’s FA Score has 1 green FA rating(s).
- BYSI’s FA Score: 2 green, 3 red.
- VNDA’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BYSI’s TA Score shows that 5 TA indicator(s) are bullish while VNDA’s TA Score has 4 bullish TA indicator(s).
- BYSI’s TA Score: 5 bullish, 5 bearish.
- VNDA’s TA Score: 4 bullish, 4 bearish.
Price Growth
BYSI (@Biotechnology) experienced а +49.34% price change this week, while VNDA (@Biotechnology) price change was -5.49% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +0.20%. For the same industry, the average monthly price growth was -14.01%, and the average quarterly price growth was -15.33%.
Reported Earning Dates
BYSI is expected to report earnings on Nov 11, 2026.
VNDA is expected to report earnings on Feb 10, 2027.
Industries' Descriptions
@Biotechnology (+0.20% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
BYSI and
Correlation & Price change
A.I.dvisor indicates that over the last year, BYSI has been loosely correlated with GOSS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BYSI jumps, then GOSS could also see price increases.
| Ticker / NAME | Correlation To BYSI | 1D Price Change % | ||
|---|---|---|---|---|
| BYSI | 100% | +24.60% | ||
| GOSS - BYSI | 38% Loosely correlated | -2.90% | ||
| CYTK - BYSI | 37% Loosely correlated | -0.51% | ||
| VNDA - BYSI | 33% Poorly correlated | -6.42% | ||
| TAOX - BYSI | 31% Poorly correlated | -10.44% | ||
| RCUS - BYSI | 31% Poorly correlated | -2.26% | ||
More | ||||
VNDA and
Correlation & Price change
A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with DYN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then DYN could also see price increases.
| Ticker / NAME | Correlation To VNDA | 1D Price Change % | ||
|---|---|---|---|---|
| VNDA | 100% | -6.42% | ||
| DYN - VNDA | 40% Loosely correlated | -2.05% | ||
| IVF - VNDA | 40% Loosely correlated | -10.46% | ||
| ARVN - VNDA | 38% Loosely correlated | -0.51% | ||
| EDIT - VNDA | 37% Loosely correlated | -8.87% | ||
| KYTX - VNDA | 37% Loosely correlated | -3.08% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBBS | 50.24 | 0.08 | +0.15% |
| BondBloxx BBB Rated 1-5 Year Corporate Bond ETF (BBBS) | |||
| CPSA | 28.25 | N/A | N/A |
| Calamos S&P 500 Structured Alt Protection ETF August (CPSA) | |||
| JGLO | 70.74 | -1.18 | -1.64% |
| JPMorgan Global Select Equity ETF Global Select Equity ETF (JGLO) | |||
| XBTY | 5.39 | -0.13 | -2.42% |
| GraniteShares YieldBOOST Bitcoin ETF (XBTY) | |||
| PTF | 99.62 | -5.71 | -5.42% |
| Invesco Dorsey Wright Technology Momentum ETF (PTF) | |||